SYNTAXIN
Syntaxin is a biopharmaceutical company that engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine diseases. The biopharmaceutical company's proprietary technology platform enables the engineering of bacterial proteins by domain substitution, to produce novel cell-specific biotherapeutics that inhibit cell secretion. These products can have therapeutic effects in a wide range of indications.
SYNTAXIN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.syntaxin.com
Total Employee:
1001+
Status:
Active
Contact:
+33 1 58 33 50 00
Email Addresses:
[email protected]
Total Funding:
71.39 M USD
Technology used in webpage:
Apache Network Solutions DNS Citrix NetScaler Confluence Networks
Similar Organizations
Alnara Pharmaceuticals
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Inexia
Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.
MYR GmbH
MYR is a biotechnology company developing and commercilizing therapeutics for the treatment of chronic hepatitis B and D infections.
Current Advisors List
Founder
Investors List
SR One
SR One investment in Series C - Syntaxin
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Syntaxin
Ipsen
Ipsen investment in Series C - Syntaxin
Seventure Partners
Seventure Partners investment in Series C - Syntaxin
Abingworth
Abingworth investment in Series C - Syntaxin
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Syntaxin
LSP BioVentures
LSP BioVentures investment in Series C - Syntaxin
SR One
SR One investment in Series B - Syntaxin
Quest for Growth
Quest for Growth investment in Series B - Syntaxin
EQT Life Sciences
EQT Life Sciences investment in Series B - Syntaxin
Official Site Inspections
http://www.syntaxin.com
- Host name: 64.190.63.222
- IP address: 64.190.63.222
- Location: Cleveland United States
- Latitude: 41.5043
- Longitude: -81.6786
- Metro Code: 510
- Timezone: America/New_York
- Postal: 44114
More informations about "Syntaxin"
Syntaxin - Crunchbase Company Profile & Funding
Syntaxin is a biopharmaceutical company that engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine diseases.See details»
The Story of Syntaxis
Should you choose to work with Syntaxis, you will see this passion in the work they do for your organization and your employees. Thank you for considering Syntaxis for your training needs! …See details»
Syntaxis - Crunchbase Company Profile & Funding
Syntaxis is located in New York, New York, United States. Who are Syntaxis 's competitors? Alternatives and possible competitors to Syntaxis may include Safety Training Services , …See details»
Contact Syntaxis about Communication Skills Training
We'd be glad to learn more about your organization and discuss how we can help! Think you’re a grammar pro? Put it to the test in a Syntaxis Grammar Quiz! About. Our Story Principals …See details»
Syntaxis Communication Skills Training NYC
Syntaxis trains business professionals to speak and write with authenticity, clarity, and strength. We have worked with many of the world’s leading corporations. Learn about workshops for …See details»
Leadership Team - Syntax
Prior, he managed ERP projects globally and led a technical consulting organization. With over two decades in technology, Marcelo emphasizes empowering individuals to provide …See details»
Syntaxis - Crunchbase Company Profile & Funding
Organization. Syntaxis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Syntaxis is committed to discovering, developing and …See details»
Syntaxin - Products, Competitors, Financials, Employees, …
Syntaxin 17 regulates the localization and function of PGAM5 in mitochondrial division and mitophagy. Nov 2, 2018. 12:24 EDT 2 Nov 2018 | Nature Publishing PGAM5, a mitochondrial …See details»
Syntaxin | Biotechnology - The Pharmaletter
Syntaxin is a UK-based private life sciences company pioneering the discovery and development of a new class of compounds to treat diseases in a range of therapeutic areas, through its …See details»
Syntaxin Ltd - Abingdon, United Kingdom - bionity.com
May 13, 2011 Syntaxin is a biopharmaceutical company that engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine …See details»
Ellen Jovin - Syntaxis, Inc. - LinkedIn
I recently had Ellen speak to our organization about email etiquette and social media in the workplace. Ellen was a huge hit with our audience as her presentation was fast paced, …See details»
Syntaxis, Inc. | New York NY - Facebook
Syntaxis, Inc., New York, New York. 722 likes · 7 were here. Syntaxis trains business professionals in New York and across the country to communicate with confidence and clarity.See details»
Syntax - LinkedIn
Syntax | 90,572 followers on LinkedIn. Enterprise Cloud / ERP Consulting / Managed Services | Since 1972, Syntax has been providing comprehensive technology solutions to businesses of …See details»
Communication Skills Training Clients - Syntaxis
Syntaxis trains employees of organizations in nearly every sector. We have conducted training for clients in dozens of cities around the world, including New York ...See details»
Syntactx Company Profile - Office Locations, Competitors ... - Craft
Syntactx is a contract research organization. It provides full-service, customized clinical trial experiences. The Company offers services in protocol development, regulatory affairs, clinical …See details»
Communication Skills Experts NYC - Syntaxis
Contact: [email protected] or 212-799-3019; Ellen Jovin. Co-founder Ellen Jovin teaches all the Syntaxis writing, grammar, and email etiquette workshops. Ellen, the author of …See details»
Syntaxis Capital - Crunchbase Investor Profile & Investments
Syntaxis is a mid-market mezzanine fund manager with just under €250 million. under management, founded in 2006. We have offices in Warsaw, Vienna, and. Istanbul. Team …See details»
Syntaxin Is Required for Cell Division
Oct 13, 2017 We recently identified a single family member homologue of syntaxin in the sea urchin. Syntaxin is present throughout development, and in rapidly dividing cleavage stage …See details»
Grammar Training NYC - Syntaxis
Syntaxis principal Ellen Jovin is the proprietor of the internationally acclaimed Grammar Table and the author of Rebel with a Clause: Tales & Tips from a Roving Grammarian (HarperCollins), a …See details»
Business Writing Training NYC - Syntaxis
Syntaxis principal Ellen Jovin is the proprietor of the internationally acclaimed Grammar Table and the author of Rebel with a Clause: Tales & Tips from a Roving Grammarian (HarperCollins), a …See details»